These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36520294)

  • 61. Temporal trends of concentrations of per- and polyfluoroalkyl substances among adults with overweight and obesity in the United States: Results from the Diabetes Prevention Program and NHANES.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
    Environ Int; 2021 Dec; 157():106789. PubMed ID: 34333293
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum per- and polyfluoroalkyl substance concentrations in four municipal US fire departments.
    Burgess JL; Fisher JM; Nematollahi A; Jung AM; Calkins MM; Graber JM; Grant CC; Beitel SC; Littau SR; Gulotta JJ; Wallentine DD; Hughes RJ; Popp C; Calafat AM; Botelho JC; Coleman AD; Schaefer-Solle N; Louzado-Feliciano P; Oduwole SO; Caban-Martinez AJ
    Am J Ind Med; 2023 May; 66(5):411-423. PubMed ID: 35864570
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Healthy eating index and diet diversity score as determinants of serum perfluoroalkyl acid (PFAA) concentrations in a national survey of Swedish adolescents.
    Nyström J; Benskin JP; Plassmann M; Sandblom O; Glynn A; Lampa E; Gyllenhammar I; Lignell S; Moraeus L
    Environ Res; 2022 Sep; 212(Pt A):113170. PubMed ID: 35339470
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Exposure to perfluoroalkyl substances (PFAS) and dyslipidemia, hypertension and obesity in adolescents. The Fit Futures study.
    Averina M; Brox J; Huber S; Furberg AS
    Environ Res; 2021 Apr; 195():110740. PubMed ID: 33460636
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies.
    Mamsen LS; Björvang RD; Mucs D; Vinnars MT; Papadogiannakis N; Lindh CH; Andersen CY; Damdimopoulou P
    Environ Int; 2019 Mar; 124():482-492. PubMed ID: 30684806
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association between early-childhood exposure to perfluoroalkyl substances and ADHD symptoms: A prospective cohort study.
    Kim JI; Kim BN; Lee YA; Shin CH; Hong YC; Døssing LD; Hildebrandt G; Lim YH
    Sci Total Environ; 2023 Jun; 879():163081. PubMed ID: 36972880
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFAS) and child executive function and behavioral problems.
    Harris MH; Oken E; Rifas-Shiman SL; Calafat AM; Bellinger DC; Webster TF; White RF; Sagiv SK
    Environ Res; 2021 Nov; 202():111621. PubMed ID: 34237332
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Association between per and polyfluoroalkyl substances and markers of inflammation and oxidative stress.
    Omoike OE; Pack RP; Mamudu HM; Liu Y; Strasser S; Zheng S; Okoro J; Wang L
    Environ Res; 2021 May; 196():110361. PubMed ID: 33131681
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Perfluoroalkyl acids serum concentrations and their relationship to biomarkers of renal failure: Serum and urine albumin, creatinine, and albumin creatinine ratios across the spectrum of glomerular function among US adults.
    Jain RB; Ducatman A
    Environ Res; 2019 Jul; 174():143-151. PubMed ID: 31077989
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Associations between Per- and Polyfluoroalkyl Substances (PFAS) and Cardiometabolic Biomarkers in Adults of Czechia: The Kardiovize Study.
    Maranhao Neto GA; Polcrova AB; Pospisilova A; Blaha L; Klanova J; Bobak M; Gonzalez-Rivas JP
    Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36360776
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dietary characteristics associated with plasma concentrations of per- and polyfluoroalkyl substances among adults with pre-diabetes: Cross-sectional results from the Diabetes Prevention Program Trial.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Fleisch AF; Calafat AM; Sanchez-Guerra M; Osorio-Yáñez C; Webster TF; Horton ES; Oken E
    Environ Int; 2020 Apr; 137():105217. PubMed ID: 32086073
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Perfluoroalkyl Substances and Abdominal Aortic Calcification.
    Koskela A; Ducatman A; Schousboe JT; Nahhas RW; Khalil N
    J Occup Environ Med; 2022 Apr; 64(4):287-294. PubMed ID: 35001069
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Associations of prenatal exposure to perfluoroalkyl substances with preterm birth: A family-based birth cohort study.
    Yu Y; Qin XD; Bloom MS; Chu C; Dai X; Li QQ; Chen ZX; Kong ML; Xie YQ; Meng WJ; Yang BY; Hu LW; Zeng XW; Zhao XM; Zhou Y; Dong GH
    Environ Res; 2022 Nov; 214(Pt 1):113803. PubMed ID: 35810818
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Associations between serum perfluoroalkyl acids and LINE-1 DNA methylation.
    Watkins DJ; Wellenius GA; Butler RA; Bartell SM; Fletcher T; Kelsey KT
    Environ Int; 2014 Feb; 63():71-6. PubMed ID: 24263140
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Perfluoroalkyl substances and immune cell counts in adults from the Mid-Ohio Valley (USA).
    Lopez-Espinosa MJ; Carrizosa C; Luster MI; Margolick JB; Costa O; Leonardi GS; Fletcher T
    Environ Int; 2021 Nov; 156():106599. PubMed ID: 33993002
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association between exposure to perfluoroalkyl substances and metabolic syndrome and related outcomes among older residents living near a Science Park in Taiwan.
    Lin TW; Chen MK; Lin CC; Chen MH; Tsai MS; Chan DC; Hung KY; Chen PC
    Int J Hyg Environ Health; 2020 Sep; 230():113607. PubMed ID: 32919137
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PFAS Concentrations and Cardiometabolic Traits in Highly Exposed Children and Adolescents.
    Canova C; Di Nisio A; Barbieri G; Russo F; Fletcher T; Batzella E; Dalla Zuanna T; Pitter G
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948492
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antibody response to COVID-19 vaccines among workers with a wide range of exposure to per- and polyfluoroalkyl substances.
    Porter AK; Kleinschmidt SE; Andres KL; Reusch CN; Krisko RM; Taiwo OA; Olsen GW; Longnecker MP
    Environ Int; 2022 Nov; 169():107537. PubMed ID: 36183490
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Associations between selected perfluoroalkyl acids in serum and hemoglobin in whole blood, a biomarker of anemia: Impact of deteriorating kidney function.
    Jain RB
    Environ Pollut; 2020 Aug; 263(Pt A):114458. PubMed ID: 32259739
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Determinants of plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances in pregnant women from a birth cohort in Shanghai, China.
    Tian Y; Zhou Y; Miao M; Wang Z; Yuan W; Liu X; Wang X; Wang Z; Wen S; Liang H
    Environ Int; 2018 Oct; 119():165-173. PubMed ID: 29958117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.